Several states have reached a $7 billion settlement with Purdue Pharma based on the Sackler family's role in creating the opioid crisis, New York Attorney General Letitia James announced today.

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's opioid epidemic, writes Adam Maguire.

Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...

NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying ...

Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion.

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an ...

It includes the company's owners, members of the Sackler family ... Under this new deal, the Sacklers and Purdue Pharma actually agreed to pay more - about $500 million more - than under the ...

Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve thousands of lawsuits claiming they played a role in driving the opioid addiction ...

Purdue, under the leadership of the Sackler families, invented, manufactured and aggressively marketed opioid products for decades, according to the lawsuits. States and cities across the country ...

Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement over the toll of the powerful prescription painkiller, the ...